UMC | Members

Members of the WHO Programme

Currently, 134 countries are members of the WHO Programme for International Drug Monitoring, and 29 associate member countries, in the early stages of establishing their pharmacovigilance systems, are preparing themselves for full membership.

For more information about individual members of the WHO Programme click on the map

Dark blue: Full member Light blue: Associate member White: Non-member

*This map is an approximation of actual country borders.

[{data: [
{"iso-a2":"AF",value:2016,color:"#003763",category:"Full Member", links:[{name:"General Directorate of Pharmaceutical Affairs",link:"http://gdpa.gov.af/en"}]},
{"iso-a2":"AE",value:2013,color:"#003763",category:"Full Member", links:[{name:"United Arab Emirates, Ministry of Health",link:"http://www.cpd-pharma.ae"}]},
{"iso-a2":"AL",value:2011,color:"#009ABE",category:"Associate Member", links:[{name:"National Center of Drugs Control",link:"http://www.akbpm.gov.al"}]},
{"iso-a2":"AD",value:2008,color:"#003763",category:"Full Member", links:[{name:"Service of Pharmacy",link:"http://www.salut.ad/"}]},
{"iso-a2":"AO",value:2013,color:"#003763",category:"Full Member", links:[{name:"Direccao Nacional de Medicamentos e Equipamentos",link:"dnme.co.ao"}]},
{"iso-a2":"AI",value:2008,color:"#009ABE",category:"Associate Member", links:[{name:"Princess Alexandra Hospital",link:"http://www.paho.org"}]},
{"iso-a2":"AG",value:2008,color:"#009ABE",category:"Associate Member", links:[{name:"Mount St. John's Medical Centre",link:"http://www.paho.org"}]},
{"iso-a2":"AR",value:1994,color:"#003763",category:"Full Member", links:[{name:"ADMINISTRACION NACIONAL DE MEDICAMENTOS ALIMENTOS Y",link:"http://www.anmat.gov.ar/farmacovigilancia/principal.asp"}]},
{"iso-a2":"AM",value:2001,color:"#003763",category:"Full Member", links:[{name:"Scientific Centre of Drug and Medical Technology",link:"http://pharm.am/index.php/en/drug-safety-profile "}]},
{"iso-a2":"AU",value:1968,color:"#003763",category:"Full Member", links:[{name:"Therapeutic Goods Administration",link:"http://www.tga.gov.au"}]},
{"iso-a2":"AT",value:1991,color:"#003763",category:"Full Member", links:[{name:"Austrian Agency for Health and Food Safety",link:"http://www.basg.gv.at/ www.ages.at"}]},
{"iso-a2":"AZ",value:2018,color:"#003763",category:"Full Member", links:[{name:"Analytical Expertise Center",link:"http://pharma.az/"}]},
{"iso-a2":"BH",value:2002,color:"#009ABE",category:"Associate Member", links:[{name:"Pharmacy and Drug Control",link:"http://www.moh.gov.bh/"}]},
{"iso-a2":"BD",value:2014,color:"#003763",category:"Full Member", links:[{name:"Directorate General of Drug Administration",link:"http://www.dgda.gov.bd/index.php/2013-03-31-04-35-57/adrm-reaction-monitoring"}]},
{"iso-a2":"BB",value:2008,color:"#003763",category:"Full Member", links:[{name:"Barbados Drug Service",link:"http://drugservice.health.gov.bb/"}]},
{"iso-a2":"BY",value:2006,color:"#003763",category:"Full Member", links:[{name:"Center for Examinations and Testing in Health Service",link:"http://rceth.by/ru/Safety"}]},
{"iso-a2":"BE",value:1977,color:"#003763",category:"Full Member", links:[{name:"Federal Agency for Medicines and Health Products",link:"http://www.basg.gv.at/en/basg-austrian-federal-office-for-safety-in-health-care/"}]},
{"iso-a2":"BJ",value:2011,color:"#003763",category:"Full Member", links:[{name:"Direction des Pharmacies et du Médicament",link:"http://www.beninsante.bj"}]},
{"iso-a2":"BT",value:2014,color:"#003763",category:"Full Member", links:[{name:"National Pharmacovigilance Centre",link:"http://dra.gov.bt/"}]},
{"iso-a2":"BO",value:2013,color:"#003763",category:"Full Member", links:[{name:"Centro Nacional de Farmacovigilancia - Bolivia",link:"http://www.minsalud.gob.bo/"}]},
{"iso-a2":"BA",value:2010,color:"#009ABE",category:"Associate Member", links:[{name:"Agency for Medicines and Medical Devices of Bosnia and Herze",link:"http://www.almbih.gov.ba/"}]},
{"iso-a2":"BW",value:2009,color:"#003763",category:"Full Member", links:[{name:"Drug Regulatory Unit",link:"http://www.moh.gov.bw/"}]},
{"iso-a2":"BR",value:2001,color:"#003763",category:"Full Member", links:[{name:"Agencia Nacional de Vigilanica Sanitaria",link:"http://portal.anvisa.gov.br/farmacovigilancia"},{name:"Universidade de Sao Paulo",link:"Not applicable"}]},
{"iso-a2":"BN",value:2005,color:"#003763",category:"Full Member", links:[{name:"National Adverse Drug Reaction Monitoring Centre",link:"http://www.moh.gov.bn/SitePages/Pharmacy%20Overview.aspx"}]},
{"iso-a2":"BG",value:1975,color:"#003763",category:"Full Member", links:[{name:"Bulgarian Drug Agency",link:"http://www.bda.bg"}]},
{"iso-a2":"BF",value:2010,color:"#003763",category:"Full Member", links:[{name:"Direction Generale de la Pharmacie (DGPML)",link:"http://www.dgpml.sante.gov.bf"}]},
{"iso-a2":"BI",value:2010,color:"#009ABE",category:"Associate Member", links:[{name:"Direction de la Pharmacie, du Médicament et des Laboratoires",link:""}]},
{"iso-a2":"CM",value:2010,color:"#003763",category:"Full Member", links:[{name:"Direction de la Pharmacie et du Médicament, Cameroon",link:""}]},
{"iso-a2":"CA",value:1968,color:"#003763",category:"Full Member", links:[{name:"Health Canada",link:"http://www.hc-sc.gc.ca"},{name:"Vaccine Preventable Diseases & Vaccine Safety",link:"http://www.phac-aspc.gc.ca"}]},
{"iso-a2":"CV",value:2012,color:"#003763",category:"Full Member", links:[{name:"Agência de Regulacâo e Supervisâo dos Produtos Farmacêuticos",link:"http://www.arfa.cv/index.php/setor-farmaceutico/farmacovigilancia"}]},
{"iso-a2":"CL",value:1996,color:"#003763",category:"Full Member", links:[{name:"Instituto de Salud Publica de Chile",link:"http://www.ispch.cl/anamed_/farmacovigilancia"}]},
{"iso-a2":"CN",value:1998,color:"#003763",category:"Full Member", links:[{name:"China Food and Drug Administration",link:"http://eng.sfda.gov.cn/WS03/CL0755/"}]},
{"iso-a2":"CO",value:2004,color:"#003763",category:"Full Member", links:[{name:"Instituto Nacional de Vigilancia de Medicamentos y Alimentos",link:"https://www.invima.gov.co/index.php?option=com_content&view=article&id=764:farmacovigilancia&catid=191:farmacovigilancia&Itemid=323"}]},
{"iso-a2":"CD",value:2010,color:"#003763",category:"Full Member", links:[{name:"Centre National de Pharmacovigilance, Congo",link:""}]},
{"iso-a2":"CR",value:1991,color:"#003763",category:"Full Member", links:[{name:"Centro Nacional de Farmacovigilancia",link:"http://www.ministeriodesalud.go.cr/index.php/regulacion-de-la-salud/farmacovigilancia"}]},
{"iso-a2":"CI",value:2010,color:"#003763",category:"Full Member", links:[{name:"Direction de la Pharmacie et du Médicament, Côte d'Ivoire",link:""}]},
{"iso-a2":"CU",value:1994,color:"#003763",category:"Full Member", links:[{name:"Centro para el Control Estatal de Med., Equip. y Disp. Med.",link:"http://www.cecmed.cu/base-legal/farmacovigilancia"}]},
{"iso-a2":"CY",value:2000,color:"#003763",category:"Full Member", links:[{name:"Pharmaceutical Services",link:"http://www.moh.gov.cy/moh/phs/phs.nsf/dmlindex_en/dmlindex_en?opendocument"}]},
{"iso-a2":"CZ",value:1992,color:"#003763",category:"Full Member", links:[{name:"State Institute for Drug Control, Czech Republic",link:"http://www.sukl.eu/index.php?lang=2"}]},
{"iso-a2":"CH",value:1991,color:"#003763",category:"Full Member", links:[{name:"Swissmedic",link:"https://www.swissmedic.ch/marktueberwachung/00135/00160/index.html?lang=en"}]},
{"iso-a2":"DE",value:1968,color:"#003763",category:"Full Member", links:[{name:"Federal Institute for Drugs and Medical Devices",link:"http://www.bfarm.de/cln_012/nn_424276/EN"},{name:"Paul Ehrlich Institut",link:"http://www.pei.de/EN/home/node.html"}]},
{"iso-a2":"DZ",value:2006,color:"#009ABE",category:"Associate Member", links:[{name:"Nouvel Institut Pasteur d'Algérie",link:"http://www.cnpm.org.dz"}]},
{"iso-a2":"DK",value:1971,color:"#003763",category:"Full Member", links:[{name:"Danish Medicines Agency",link:"http://laegemiddelstyrelsen.dk/en"}]},
{"iso-a2":"DM",value:2008,color:"#009ABE",category:"Associate Member", links:[{name:"Grand Health Center",link:"http://www.paho.org"}]},
{"iso-a2":"EC",value:2017,color:"#003763",category:"Full Member", links:[{name:"Agencia Nacional de Reg. Contr. y Vigilanc. Sanit.",link:"http://www.controlsanitario.gob.ec"}]},
{"iso-a2":"ES",value:1984,color:"#003763",category:"Full Member", links:[{name:"Spanish Agency for Medicines and Healthcare Products",link:"https://www.aemps.gob.es/vigilancia/medicamentosUsoHumano/home.htm"}]},
{"iso-a2":"ET",value:2008,color:"#003763",category:"Full Member", links:[{name:"ET Food, Medicine & Healthcare Admin and Control Authority",link:"http://www.fmhaca.gov.et/pharmacovigilance.html"}]},
{"iso-a2":"ER",value:2012,color:"#003763",category:"Full Member", links:[{name:"Eritrean National Pharmacovigilance Centre",link:"http://pveritrea.com/"}]},
{"iso-a2":"EE",value:1998,color:"#003763",category:"Full Member", links:[{name:"State Agency of Medicines",link:"http://www.ravimiamet.ee/en"}]},
{"iso-a2":"EG",value:2001,color:"#003763",category:"Full Member", links:[{name:"Egyptian Pharmaceutical Vigilance Center",link:"http://www.epvc.gov.eg/"}]},
{"iso-a2":"FJ",value:1999,color:"#003763",category:"Full Member", links:[{name:"Fiji Pharmaceutical & Biomedical Services Centre",link:"http://www.health.gov.fj"}]},
{"iso-a2":"FI",value:1974,color:"#003763",category:"Full Member", links:[{name:"Finnish Medicines Agency",link:"http://www.fimea.fi/web/en/pharmaceutical_safety_and_information"}]},
{"iso-a2":"FR",value:1986,color:"#003763",category:"Full Member", links:[{name:"Agence nationale de sécurité du méd. et des prod. de santé",link:"http://ansm.sante.fr"}]},
{"iso-a2":"GM",value:2011,color:"#009ABE",category:"Associate Member", links:[{name:"Medicines Control Agency",link:""}]},
{"iso-a2":"GE",value:2018,color:"#003763",category:"Full Member", links:[{name:"National Center of Pharmacovigilance",link:"http://moh.gov.ge"}]},
{"iso-a2":"GH",value:2001,color:"#003763",category:"Full Member", links:[{name:"Food and Drugs Authority",link:"http://www.fdaghana.gov.gh"}]},
{"iso-a2":"GR",value:1990,color:"#003763",category:"Full Member", links:[{name:"National Organization for Medicines",link:"http://www.eof.gr/web/guest/home"}]},
{"iso-a2":"GD",value:2008,color:"#009ABE",category:"Associate Member", links:[{name:"Central Medical Stores, Grenada",link:"http://www.paho.org"}]},
{"iso-a2":"GT",value:2002,color:"#003763",category:"Full Member", links:[{name:"Ministerio de Salud Publica y Asistencia Social",link:"http://www.mspas.gob.gt/index.php/en/servicios/farmacovigilancia.html"}]},
{"iso-a2":"GN",value:2013,color:"#003763",category:"Full Member", links:[{name:"Direction Nationale de la Pharmacie et des Laboratoires",link:""}]},
{"iso-a2":"GY",value:2018,color:"#009ABE",category:"Associate Member", links:[{name:"Ministry of Public Health",link:"http://www.health.gov.gy"}]},
{"iso-a2":"GW",value:2009,color:"#009ABE",category:"Associate Member", links:[{name:"Guinée-Bissau Ministério da Saúde",link:""}]},
{"iso-a2":"GB",value:1968,color:"#003763",category:"Full Member", links:[{name:"Medicines and Healthcare products Regulatory Agency",link:"http://www.mhra.gov.uk"}]},
{"iso-a2":"HR",value:1992,color:"#003763",category:"Full Member", links:[{name:"Croatian Agency for Medicinal Products and Devices",link:"http://www.halmed.hr/en/"}]},
{"iso-a2":"HU",value:1990,color:"#003763",category:"Full Member", links:[{name:"National Institute of Pharmacy and Nutrion",link:"https://www.ogyei.gov.hu/pharmacovigilance/"}]},
{"iso-a2":"HT",value:2016,color:"#009ABE",category:"Associate Member", links:[{name:"Ministère Santé Publique et de la Population",link:"http://mspp.gouv.ht/newsite/"}]},
{"iso-a2":"IS",value:1990,color:"#003763",category:"Full Member", links:[{name:"Icelandic Medicines Agency",link:"http://www.ima.is/Pharmacovigilance/"}]},
{"iso-a2":"IN",value:1998,color:"#003763",category:"Full Member", links:[{name:"Indian Pharmacopoeia Commission",link:"http://www.ipc.gov.in"}]},
{"iso-a2":"ID",value:1975,color:"#003763",category:"Full Member", links:[{name:"Indonesia National Agency of Drug and Food Control",link:"http://www.pom.go.id/new/index.php/home/en"}]},
{"iso-a2":"IR",value:1998,color:"#003763",category:"Full Member", links:[{name:"Iranian Adverse Drug Reaction Monitoring Centre",link:"http://www.mohme.gov.ir"}]},
{"iso-a2":"IQ",value:2010,color:"#003763",category:"Full Member", links:[{name:"Iraqi Pharmacovigilance Center",link:"http://www.mohiraq.org"}]},
{"iso-a2":"IE",value:1968,color:"#003763",category:"Full Member", links:[{name:"Health Products Regulatory Authority",link:"http://www.hpra.ie/homepage/medicines"}]},
{"iso-a2":"IL",value:1973,color:"#003763",category:"Full Member", links:[{name:"Department of Drug Information and Risk Management",link:"http://www.health.gov.il/English/MinistryUnits/HealthDivision/MedicalTechnologies/Drugs/risk/Pages/default.aspx"}]},
{"iso-a2":"IT",value:1975,color:"#003763",category:"Full Member", links:[{name:"Agenzia Italiana del Farmaco",link:"http://www.agenziafarmaco.gov.it/en/content/post-marketing-surveillance"}]},
{"iso-a2":"JM",value:2012,color:"#003763",category:"Full Member", links:[{name:"Pharmwatch Jamaica",link:"http://www.moh.gov.jm"}]},
{"iso-a2":"JP",value:1972,color:"#003763",category:"Full Member", links:[{name:"Pharmaceuticals and Medical Devices Agency",link:"http://www.pmda.go.jp/english/index.html"}]},
{"iso-a2":"JO",value:2002,color:"#003763",category:"Full Member", links:[{name:"Jordan Food and Drug Administration",link:"http://www.jfda.jo"}]},
{"iso-a2":"KH",value:2012,color:"#003763",category:"Full Member", links:[{name:"Cambodian Pharmacovigilance Center",link:"http://www.ddfcambodia.com"}]},
{"iso-a2":"KZ",value:2008,color:"#003763",category:"Full Member", links:[{name:"National Center for drug expertise, items for medical use an",link:"http://dari.kz/category/monitoring "}]},
{"iso-a2":"KE",value:2010,color:"#003763",category:"Full Member", links:[{name:"Pharmacy and Poisons Board",link:"http://www.pharmacyboardkenya.org"}]},
{"iso-a2":"KR",value:1992,color:"#003763",category:"Full Member", links:[{name:"Ministry of Food and Drug Safety",link:" http://www.mfds.go.kr/eng/index.do"}]},
{"iso-a2":"KG",value:2003,color:"#003763",category:"Full Member", links:[{name:"Department of Drug Provision & Medical Equipment",link:"http://pharm.kg/ru/farmakonadzor/ "}]},
{"iso-a2":"KN",value:2008,color:"#009ABE",category:"Associate Member", links:[{name:"Ministry of Health, St. Kitts and Nevis",link:"http://www.paho.org"}]},
{"iso-a2":"KW",value:2018,color:"#009ABE",category:"Associate Member", links:[]},
{"iso-a2":"LA",value:2015,color:"#003763",category:"Full Member", links:[{name:"Food and Drug Department, Ministry of Health",link:"http://www.fdd.gov.la"}]},
{"iso-a2":"LB",value:2018,color:"#009ABE",category:"Associate Member", links:[{name:"Ministry of Public Health",link:"http:/www.phcvg.ul.edu.lb"}]},
{"iso-a2":"LV",value:2002,color:"#003763",category:"Full Member", links:[{name:"State Agency of Medicines of Latvia",link:"https://www.zva.gov.lv//?id=420&sa=420&top=386"}]},
{"iso-a2":"LR",value:2013,color:"#003763",category:"Full Member", links:[{name:"Liberia Medicines and Health Products Regulatory Authority",link:"http://www.lmhralib.org/departments/pharmacovigilance/"}]},
{"iso-a2":"LT",value:2005,color:"#003763",category:"Full Member", links:[{name:"State Medicines Control Agency",link:"http://www.vvkt.lt/Pharmacovigilance"}]},
{"iso-a2":"LC",value:2008,color:"#009ABE",category:"Associate Member", links:[{name:"OECS - Pharmaceutical Procurement Service",link:"http://www.oecs.org/"},{name:"Ministry of Health, St Lucia",link:"http://www.paho.org"}]},
{"iso-a2":"LK",value:2000,color:"#003763",category:"Full Member", links:[{name:"National Medicines Regulatory Authority",link:"http://www.cdda.gov.lk"}]},
{"iso-a2":"LY",value:2018,color:"#009ABE",category:"Associate Member", links:[{name:"Ministry of Health",link:"http://www.health.gov.ly/"}]},
{"iso-a2":"MK",value:2000,color:"#003763",category:"Full Member", links:[{name:"Macedonian Agency for medicines and medical devices",link:"http://www.moh.gov.mk "}]},
{"iso-a2":"MG",value:2009,color:"#003763",category:"Full Member", links:[{name:"Agence du Médicament de Madagascar",link:"http://www.sante.gov.mg"}]},
{"iso-a2":"MW",value:2016,color:"#009ABE",category:"Associate Member", links:[{name:"Pharmacy, Medicines and Poisons Board",link:"http://www.health.gov.mw "}]},
{"iso-a2":"MY",value:1990,color:"#003763",category:"Full Member", links:[{name:"National Pharmaceutical Control Bureau",link:"http://npra.moh.gov.my"}]},
{"iso-a2":"MV",value:2016,color:"#003763",category:"Full Member", links:[{name:"Maldives Food and Drug Authority",link:"http://www.mfda.gov.mv/English/index.php"}]},
{"iso-a2":"ML",value:2011,color:"#003763",category:"Full Member", links:[{name:"Centre National de Pharmacovigilance, Mali",link:""}]},
{"iso-a2":"MM",value:2018,color:"#009ABE",category:"Associate Member", links:[{name:"Department of Food and Drug Administration, Ministry of Health and Sports",link:"http://www.fdamyanmar.gov.mm/"}]},
{"iso-a2":"MT",value:2004,color:"#003763",category:"Full Member", links:[{name:"Malta Medicines Authority",link:"http://www.medicinesauthority.gov.mt"}]},
{"iso-a2":"MU",value:2014,color:"#003763",category:"Full Member", links:[{name:"National PV centre of Mauritius",link:""}]},
{"iso-a2":"MX",value:1999,color:"#003763",category:"Full Member", links:[{name:"Federal Commission for the Protection against Sanitary Risk",link:"http://www.cofepris.gob.mx/AZ/Paginas/Farmacovigilancia/Farmacovigilancia.aspx"}]},
{"iso-a2":"MD",value:2003,color:"#003763",category:"Full Member", links:[{name:"Medicines Agency",link:"http://amed.md/en/content/pharmacovigilance "}]},
{"iso-a2":"MN",value:2005,color:"#009ABE",category:"Associate Member", links:[{name:"Drug Regulation Division, Center for Health Development",link:""}]},
{"iso-a2":"ME",value:2009,color:"#003763",category:"Full Member", links:[{name:"Agency for Medicines and Medical Devices",link:"http://www.mzd.gov.me"}]},
{"iso-a2":"MS",value:2008,color:"#009ABE",category:"Associate Member", links:[{name:"Glendon Hospital Pharmacy",link:"http://www.paho.org"}]},
{"iso-a2":"MA",value:1992,color:"#003763",category:"Full Member", links:[{name:"Centre Anti Poison et de Pharmacovigilance",link:"http://www.capm.ma"}]},
{"iso-a2":"MZ",value:2005,color:"#003763",category:"Full Member", links:[{name:"Pharmaceutical Department",link:"http://www.misau.gov.mz/index.php"}]},
{"iso-a2":"NA",value:2008,color:"#003763",category:"Full Member", links:[{name:"Namibia Medicines Regulatory Council",link:"http://www.nmrc.com.na/tipc"}]},
{"iso-a2":"NP",value:2006,color:"#003763",category:"Full Member", links:[{name:"Department of Drug Administration",link:"http://www.dda.gov.np"}]},
{"iso-a2":"NL",value:1968,color:"#003763",category:"Full Member", links:[{name:"Netherlands Pharmacovigilance Centre Lareb",link:"http://www.lareb.nl/?lang=en-GB"}]},
{"iso-a2":"NZ",value:1968,color:"#003763",category:"Full Member", links:[{name:"New Zealand Pharmacovigilance Centre",link:"http://www.otago.ac.nz/carm"}]},
{"iso-a2":"NE",value:2012,color:"#003763",category:"Full Member", links:[{name:"Direction de la Pharmacie, des Laboratoires et de la Médecin",link:""}]},
{"iso-a2":"NG",value:2004,color:"#003763",category:"Full Member", links:[{name:"National Agency for Food and Drug Administration and Control",link:"http://www.nafdac.gov.ng/index.php/about-nafdac/faqs/pharmacovigilance"}]},
{"iso-a2":"NO",value:1971,color:"#003763",category:"Full Member", links:[{name:"Norwegian Medicines Agency",link:"https://legemiddelverket.no/English"}]},
{"iso-a2":"OM",value:1995,color:"#003763",category:"Full Member", links:[{name:"Directorate General Pharmaceutical Affairs and Drug Control",link:"https://www.moh.gov.om/en_US/web/dgpadc"}]},
{"iso-a2":"PK",value:1994,color:"#009ABE",category:"Associate Member", links:[{name:"Drug Regulatory Authority of Pakistan",link:"http://www.dra.gov.pk"}]},
{"iso-a2":"PA",value:2005,color:"#003763",category:"Full Member", links:[{name:"Dirección Nacional de Farmacia y Drogas del Minist. de Salud",link:"http://www.minsa.gob.pa/informacion-salud/centro-nacional-de-farmacovigilancia"}]},
{"iso-a2":"PG",value:2018,color:"#003763",category:"Full Member", links:[{name:"Papua New Guinea Drug Information and Pharmacovigilance Unit",link:"http://www.health.gov.pg"}]},
{"iso-a2":"PE",value:2002,color:"#003763",category:"Full Member", links:[{name:"Direccion General de Medicamentos, Insumos y Drogas",link:"http://www.digemid.minsa.gob.pe/main.asp?Seccion=572"}]},
{"iso-a2":"PH",value:1995,color:"#003763",category:"Full Member", links:[{name:"Food and Drug Administration, Philippines",link:"http://www.fda.gov.ph"}]},
{"iso-a2":"PK",value:2018,color:"#003763",category:"Full Member", links:[{name:"Drug Regulatory Authority of Pakistan",link:"http://www.dra.gov.pk/"}]},
{"iso-a2":"PL",value:1972,color:"#003763",category:"Full Member", links:[{name:"Office for Registration of Medicinal Products, URPL",link:"http://www.urpl.gov.pl/en"}]},
{"iso-a2":"PT",value:1993,color:"#003763",category:"Full Member", links:[{name:"INFARMED",link:"http://www.infarmed.pt/web/infarmed/entidades/medicamentos-uso-humano/farmacovigilancia"}]},
{"iso-a2":"PY",value:2018,color:"#003763",category:"Full Member", links:[{name:"Dirección Nacional de Vigilancia Sanitaria",link:"https://www.mspbs.gov.py/dnvs"}]},
{"iso-a2":"QA",value:2013,color:"#009ABE",category:"Associate Member", links:[{name:"Supreme Council of Health",link:"https://www.moph.gov.qa/home-en"}]},
{"iso-a2":"RO",value:1976,color:"#003763",category:"Full Member", links:[{name:"National Agency for Medicines and Medical Devices",link:"http://www.anm.ro/anmdm/en/index.html"}]},
{"iso-a2":"RU",value:1998,color:"#003763",category:"Full Member", links:[{name:"Federal Service on Surveillance in Healthcare and Soc.Dev",link:"http://www.roszdravnadzor.ru/drugs/monitpringlp "}]},
{"iso-a2":"RW",value:2013,color:"#003763",category:"Full Member", links:[{name:"Pharmacy Task Force, Ministry of Health",link:"http://www.moh.gov.rw"}]},
{"iso-a2":"RS",value:2000,color:"#003763",category:"Full Member", links:[{name:"Medicines and Medical Devices Agency of Serbia",link:"http://www.alims.gov.rs"}]},
{"iso-a2":"SV",value:2017,color:"#003763",category:"Full Member", links:[{name:"Ministerio de Salud de El Salvador",link:"http://www.salud.gob.sv"}]},
{"iso-a2":"SA",value:2009,color:"#003763",category:"Full Member", links:[{name:"Saudi Food and Drug Authority",link:"http://www.sfda.gov.sa/EN/DRUG/ABOUT/SECTOR_DEPARTMENTS/NATIONAL_PHARMACOVIGILANCE_CENTER/Pages/default.aspx"}]},
{"iso-a2":"SS",value:2018,color:"#009ABE",category:"Associate Member",links:[{name:"",link:""}]},
{"iso-a2":"SN",value:2009,color:"#003763",category:"Full Member", links:[{name:"Direction de la Pharmacie et des Laboratoires",link:"http://www.sante.gouv.sn"}]},
{"iso-a2":"SL",value:2008,color:"#003763",category:"Full Member", links:[{name:"Pharmacy Board of Sierra Leone",link:"http://www.pharmacyboard.gov.sl"}]},
{"iso-a2":"SG",value:1993,color:"#003763",category:"Full Member", links:[{name:"Health Sciences Authority",link:"http://www.hsa.gov.sg"}]},
{"iso-a2":"SK",value:1993,color:"#003763",category:"Full Member", links:[{name:"State Institute for Drug Control, Slovakia",link:"http://www.sukl.sk/en/drug-safety/scope-of-activities?page_id=4020"}]},
{"iso-a2":"SI",value:2010,color:"#003763",category:"Full Member", links:[{name:"Agency for medicinal products and medical devices",link:"http://www.jazmp.si/en/"}]},
{"iso-a2":"SD",value:2008,color:"#003763",category:"Full Member", links:[{name:"National Medicines and Poisons Board",link:"http://www.nmpb.gov.sd/"}]},
{"iso-a2":"SR",value:2007,color:"#003763",category:"Full Member", links:[{name:"Office of Pharmacy Policy",link:""}]},
{"iso-a2":"SZ",value:2015,color:"#003763",category:"Full Member", links:[{name:"Swaziland Pharmacovigilance Centre - Central Medical Stores",link:"http://www.gov.sz/index.php?option=com_content&view=article&id=267&Itemid=403"}]},
{"iso-a2":"SE",value:1968,color:"#003763",category:"Full Member", links:[{name:"Medical Products Agency",link:"https://lakemedelsverket.se/english/"}]},
{"iso-a2":"SY",value:2018,color:"#003763",category:"Full Member", links:[{name:"Syrian Ministry of Health",link:"http://www.moh.gov.sy"}]},
{"iso-a2":"TD",value:2018,color:"#003763",category:"Full Member", links:[{name:"Bureau de Pharmacovigilance",link:"http://www.sante-tchad.org"}]},
{"iso-a2":"TZ",value:1993,color:"#003763",category:"Full Member", links:[{name:"Tanzania Food and Drugs Authority",link:"http://www.tfda.or.tz"}]},
{"iso-a2":"TH",value:1984,color:"#003763",category:"Full Member", links:[{name:"Thai Food and Drug Administration",link:"http://thaihpvc.fda.moph.go.th/thaihvc/index.jsf"}]},
{"iso-a2":"TG",value:2007,color:"#003763",category:"Full Member", links:[{name:"Direction des Pharmacies, Togo",link:"http://www.everyoneweb.fr/pharmacovigilance"}]},
{"iso-a2":"TN",value:1993,color:"#003763",category:"Full Member", links:[{name:"Centre National de Pharmacovigilance, Tunisia",link:""}]},
{"iso-a2":"TR",value:1987,color:"#003763",category:"Full Member", links:[{name:"Turkish Pharmacovigilance Center",link:"http://www.titck.gov.tr"}]},
{"iso-a2":"TJ",value:2015,color:"#009ABE",category:"Associate Member", links:[{name:"Office of National Supervision for Pharmaceutical Activities",link:"http://www.pharmnadzor.tj/index.html"}]},
{"iso-a2":"UG",value:2007,color:"#003763",category:"Full Member", links:[{name:"National Drug Authority",link:"http://www.nda.or.ug"}]},
{"iso-a2":"UA",value:2002,color:"#003763",category:"Full Member", links:[{name:"State Expert Center",link:"http://www.dec.gov.ua/index.php/ua/farmakonaglyad "}]},
{"iso-a2":"US",value:1968,color:"#003763",category:"Full Member", links:[{name:"US FDA, Center for Biologics Evaluation and Research",link:"http://www.fda.gov/cber"},{name:"US FDA, Center for Drug Evaluation and Research",link:"http://www.fda.gov/cder"}]},
{"iso-a2":"UY",value:2001,color:"#003763",category:"Full Member", links:[{name:"Department of Pharmaceuticals",link:"http://www.msp.gub.uy"}]},
{"iso-a2":"UZ",value:2006,color:"#003763",category:"Full Member", links:[{name:"Pharmacological Committee of HDDMEC",link:"http://pharm-reg.uz/info/structure/farmakolog/ "}]},
{"iso-a2":"VC",value:2008,color:"#009ABE",category:"Associate Member", links:[{name:"SVG Pharmacovigilance & Drug Information Centre",link:"http://www.paho.org"}]},
{"iso-a2":"VE",value:1995,color:"#003763",category:"Full Member", links:[{name:"Instituto Nacional de Higiene, Rafael Rangel",link:"http://www.inhrr.gob.ve/sistema_nacional_farmacovigilancia_ce.php"}]},
{"iso-a2":"VN",value:1999,color:"#003763",category:"Full Member", links:[{name:"National Centre of Drug Information & Adverse Drug Reactions",link:"http://canhgiacduoc.org.vn/en.aspx"}]},
{"iso-a2":"VI",value:2008,color:"#009ABE",category:"Associate Member", links:[{name:"Drugs & Pharmaceutical Services",link:"http://www.paho.org"}]},
{"iso-a2":"YE",value:2018,color:"#009ABE",category:"Associate Member", links:[{name:"Supreme Board of Drugs and Medical Appliances",link:"http://www.sbd-ye.org/"}]},
{"iso-a2":"ZA",value:1992,color:"#003763",category:"Full Member", links:[{name:"Medicines Regulatory Authority",link:"http://www.mccza.com/"}]},
{"iso-a2":"Zanzi",value:2007,color:"#009ABE",category:"Associate Member", links:[{name:"Zanzibar Food and Drugs Board",link:"http://www.zfdb.go.tz"}]},
{"iso-a2":"ZM",value:2010,color:"#003763",category:"Full Member", links:[{name:"Zambia Medicines Regulatory Authority",link:"http://www.zamra.co.zm"}]},
{"iso-a2":"ZW",value:1998,color:"#003763",category:"Full Member", links:[{name:"Medicines Control Authority of Zimbabwe",link:"http://www.mcaz.co.zw"}]}],joinBy: 'iso-a2',name: 'Member status',mapData: Highcharts.maps['custom/world-palestine'],states: { hover: { color: '#a02741' }}}]

Members

View the list of full members and associate members

See list
Country guidelines

Download pharmacovigilance guidelines from selected countries.

See list
WHO Programme

Read more about the WHO Programme and what it means to be a member

Read more

Members

Members of the WHO Programme

Members

Country guidelines

WHO Programme